GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aurora Spine Corp (TSXV:ASG) » Definitions » EBITDA Margin %

Aurora Spine (TSXV:ASG) EBITDA Margin % : 7.39% (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Aurora Spine EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Aurora Spine's EBITDA for the three months ended in Sep. 2024 was C$0.48 Mil. Aurora Spine's Revenue for the three months ended in Sep. 2024 was C$6.46 Mil. Therefore, Aurora Spine's EBITDA margin for the quarter that ended in Sep. 2024 was 7.39%.


Aurora Spine EBITDA Margin % Historical Data

The historical data trend for Aurora Spine's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurora Spine EBITDA Margin % Chart

Aurora Spine Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.22 -6.64 -14.72 -3.15 -3.07

Aurora Spine Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.38 1.31 1.90 2.43 7.39

Competitive Comparison of Aurora Spine's EBITDA Margin %

For the Medical Devices subindustry, Aurora Spine's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aurora Spine's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aurora Spine's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Aurora Spine's EBITDA Margin % falls into.



Aurora Spine EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Aurora Spine's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-0.598/19.48
=-3.07 %

Aurora Spine's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=0.477/6.457
=7.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aurora Spine  (TSXV:ASG) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Aurora Spine EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Aurora Spine's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aurora Spine Business Description

Traded in Other Exchanges
Address
20 Holly Street, Suite 300, Toronto, ON, CAN, M4S 3B1
Aurora Spine Corp is engaged in the business of the development and commercialization of minimally invasive interspinous fusion systems and devices. The product portfolio includes implants, surgical tools, and biologics. It derives revenues primarily from the sale of spinal surgery implants, consumable products used in spinal surgeries, and service revenue for referring products to its customers.
Executives
James Snow Director
Trent James Northcutt 10% Security Holder, Director, Senior Officer
Chad Clouse Senior Officer
David Aubrey Rosenkrantz Director